title: B-type natriuretic peptide and the effect of ranolazine in patients with non-ST-segment elevation acute coronary syndromes: observations from the MERLIN-TIMI 36 (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST Elevation Acute Coronary-Thrombolysis In Myocardial Infarction 36) trial.
authors.affiliation: TIMI Study Group, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. Electronic address: dmorrow@partners.org.
authors.forename: David A
authors.initials: DA
authors.lastname: Morrow
authors.affiliation: TIMI Study Group, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Benjamin M
authors.initials: BM
authors.lastname: Scirica
authors.affiliation: TIMI Study Group, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Marc S
authors.initials: MS
authors.lastname: Sabatine
authors.affiliation: University of Texas Southwestern Medical School, Dallas, Texas.
authors.forename: James A
authors.initials: JA
authors.lastname: de Lemos
authors.affiliation: TIMI Study Group, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Sabina A
authors.initials: SA
authors.lastname: Murphy
authors.affiliation: Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Petr
authors.initials: P
authors.lastname: Jarolim
authors.affiliation: Montreal Heart Institute, Montreal, Quebec, Canada.
authors.forename: Pierre
authors.initials: P
authors.lastname: Theroux
authors.affiliation: Medizinische Universitatsklinik, University of Freiburg, Freiburg, Germany.
authors.forename: Christophe
authors.initials: C
authors.lastname: Bode
authors.affiliation: TIMI Study Group, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
authors.forename: Eugene
authors.initials: E
authors.lastname: Braunwald
mesh_terms: D000083:Acetanilides / Q000494:pharmacology*; D054058:Acute Coronary Syndrome / Q000175:diagnosis* / Q000188:drug therapy*; D000368:Aged; D015415:Biomarkers / Q000097:blood; D004311:Double-Blind Method; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D020097:Natriuretic Peptide, Brain / Q000097:blood*; D010879:Piperazines / Q000494:pharmacology*; D000069458:Ranolazine; D012307:Risk Factors
chemical_list: D000083:Acetanilides; D015415:Biomarkers; D004791:Enzyme Inhibitors; D010879:Piperazines; D020097:Natriuretic Peptide, Brain; D000069458:Ranolazine